Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease
Status:
Terminated
Trial end date:
2021-03-22
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of intravenous (IV) infusions of pamrevlumab
when compared with placebo in participants who are hospitalized with acute COVID-19 disease.